{"id":103579,"date":"2023-05-30T12:53:20","date_gmt":"2023-05-30T07:23:20","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=103579"},"modified":"2023-05-30T12:53:22","modified_gmt":"2023-05-30T07:23:22","slug":"cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/","title":{"rendered":"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2249161446\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-68059815\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The company&#8217;s net profit increased by 4708% to&nbsp; Rs 11.06 crore in Q4FY23 from Rs 0.23 crore in Q4FY22. Additionally, revenue from operations increased by 9.9 % to Rs 159.05 crore from Rs 144.70 crore in the corresponding quarter last year.<\/p><p><a href=\"https:\/\/portal.tradebrains.in\/stock\/VENUSREM\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Venus Remedies Ltd<\/strong><\/a> is engaged in the manufacturing of pharmaceutical products for anti-cancer drugs. And company works on in-house research and development activities that focus on Formulation Development, Novel Drug Delivery Systems, new formulations of off-patented chemicals, and analytical and chemical research.<\/p><p>As per consolidated financials, the company reported operating revenue increased from \u20b9120.89 crores in Q3 to \u20b9159.05 crores in Q4. Similarly, the net profits of the company during the same period, increased by 236&nbsp; percent from \u20b93.29 crore to \u20b9 11.06 crore.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1919909606\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>On a YoY comparison of the metrics, the revenues reduced from \u20b9 608.49 crores during FY 21-22 to \u20b9565.83 crores in FY 22-23. The PAT numbers have declined within the timeframe mentioned, from \u20b9 40.72 crores to \u20b926.57 crores.&nbsp;<\/p><p>According to the latest data pertaining to the shareholding pattern, promoters of the company hold a 41.76 percent stake, and the public holds a 57.11 percent stake in the company for FY 22-23.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By Omkar C<\/strong><\/p><\/blockquote><h3 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h3><div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer.png\" alt=\"\" class=\"wp-image-26306\" width=\"256\" height=\"256\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2003905827\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023. The company&#8217;s net profit increased by 4708% [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":97870,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[8797,6555,6923,936,6007,3153,3157,6126,6127,4787],"class_list":["post-103579","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-latest-stock-market-news","tag-small-cap-stock-with-high-returns","tag-stock-market-gainers-today","tag-stock-market-news","tag-stock-market-recent-news","tag-stock-to-buy","tag-stock-to-watch","tag-stocks-that-hit-20-upper-circuit","tag-stocks-that-hit-20-upper-circuit-today","tag-upper-circuit-stocks"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4\" \/>\n<meta property=\"og:description\" content=\"Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-30T07:23:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-30T07:23:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/\",\"url\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/\",\"name\":\"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg\",\"datePublished\":\"2023-05-30T07:23:20+00:00\",\"dateModified\":\"2023-05-30T07:23:22+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4 - Trade Brains Features","description":"Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/","og_locale":"en_US","og_type":"article","og_title":"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4","og_description":"Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.","og_url":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-05-30T07:23:20+00:00","article_modified_time":"2023-05-30T07:23:22+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/","url":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/","name":"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg","datePublished":"2023-05-30T07:23:20+00:00","dateModified":"2023-05-30T07:23:22+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of Venus Remedies Ltd, shot up 20 percent on Tuesday\u2019s early trade to hit the 20 percent upper circuit. Company shares were locked at \u20b9 236.75 apiece on the National Stock Exchange (NSE). After the company announced strong earnings for the period ending on March 31, 2023.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/03\/market-cover-image-1.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/cancer-drug-manufacturer-stock-hits-20-upper-circuit-after-net-profit-jumps-200-in-q4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Cancer drug manufacturer stock hits 20% upper circuit after net profit jumps 200% in Q4"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/103579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=103579"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/103579\/revisions"}],"predecessor-version":[{"id":103580,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/103579\/revisions\/103580"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/97870"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=103579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=103579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=103579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}